Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Landin-Olsson, M.
Right arrow Articles by Sundkvist, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landin-Olsson, M.
Right arrow Articles by Sundkvist, G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 41, Issue 8 1022-1027, Copyright © 1992 by American Diabetes Association


ARTICLES

Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden

M Landin-Olsson, FA Karlsson, A Lernmark and G Sundkvist
Department of Medicine, University of Lund, Malmo General Hospital, Sweden.

The effect of age on ICA and thyrogastric antibodies at diagnosis of IDDM was evaluated in 633 consecutively diagnosed Swedish diabetic patients aged 15-34 yr and in 282 volunteers of the same age. ICAs were present in 61% (383 of 633) of the patients and in 2% (5 of 282) of control subjects. When the initial classification was considered, ICAs were detected in 69% (327 of 473) of patients with IDDM, 23% (19 of 83) of those with NIDDM, 50% (36 of 72) of those with unclassifiable diabetes, and 20% (1 of 5) of those with secondary diabetes. The frequency of ICA fell significantly (P less than 0.001) with age in IDDM patients from 77% (104/135) in those 15-19 yr old to 52% (50 of 96) in 30- to 34-yr-old IDDM patients. The low frequency of ICA in 30- to 34-yr-old IDDM patients was confined to men (42%, 28 of 66). The frequency of gastric (H+, K(+)-ATPase) antibodies was significantly (P less than 0.05) higher in IDDM patients (10%, 47 of 449) than in patients with NIDDM (3%, 3 of 80) and unclassifiable diabetes (4%, 3 of 72). In conclusion, the frequency of ICA at the diagnosis of IDDM in young adult subjects decreases with increasing age, particularly in men. The frequent finding of ICA in patients considered to have NIDDM or unclassifiable diabetes indicates that misclassification of diabetes is frequent in young adult patients recently diagnosed with diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
T. Tuomi
Type 1 and Type 2 Diabetes: What Do They Have in Common?
Diabetes, December 1, 2005; 54(suppl_2): S40 - S45.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
G. Stenstrom, A. Gottsater, E. Bakhtadze, B. Berger, and G. Sundkvist
Latent Autoimmune Diabetes in Adults: Definition, Prevalence, {beta}-Cell Function, and Treatment
Diabetes, December 1, 2005; 54(suppl_2): S68 - S72.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Svensson, G. Sundkvist, H. J. Arnqvist, E. Bjork, G. Blohme, J. Bolinder, M. Henricsson, L. Nystrom, O. Torffvit, I. Waernbaum, et al.
Signs of Nephropathy May Occur Early in Young Adults With Diabetes Despite Modern Diabetes Management: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)
Diabetes Care, October 1, 2003; 26(10): 2903 - 2909.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. Pundziute-Lycka, B. Urbonaite, R. Ostrauskas, R. Zalinkevicius, and G. G. Dahlquist
Incidence of Type 1 Diabetes in Lithuanians Aged 0-39 Years Varies by the Urban-Rural Setting, and the Time Change Differs for Men and Women During 1991-2000
Diabetes Care, March 1, 2003; 26(3): 671 - 676.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Henricsson, L. Nystrom, G. Blohme, J. Ostman, C. Kullberg, M. Svensson, A. Scholin, H. J. Arnqvist, E. Bjork, J. Bolinder, et al.
The Incidence of Retinopathy 10 Years After Diagnosis in Young Adult People With Diabetes: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS)
Diabetes Care, February 1, 2003; 26(2): 349 - 354.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Graham, W. A. Hagopian, I. Kockum, L. S. Li, C. B. Sanjeevi, R. M. Lowe, J. B. Schaefer, M. Zarghami, H. L. Day, M. Landin-Olsson, et al.
Genetic Effects on Age-Dependent Onset and Islet Cell Autoantibody Markers in Type 1 Diabetes
Diabetes, May 1, 2002; 51(5): 1346 - 1355.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. Lethagen, U.-B. Ericsson, B. Hallengren, L. Groop, and T. Tuomi
Glutamic Acid Decarboxylase Antibody Positivity Is Associated with an Impaired Insulin Response to Glucose and Arginine in Nondiabetic Patients with Autoimmune Thyroiditis
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1177 - 1183.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
B. Littorin, G. Sundkvist, L. Nyström, A. Carlson, M. Landin-Olsson, J. Östman, H. J. Arnqvist, E. Björk, G. Blohmé, J. Bolinder, et al.
Family Characteristics and Life Events Before the Onset of Autoimmune Type 1 Diabetes in Young Adults: A nationwide study
Diabetes Care, June 1, 2001; 24(6): 1033 - 1037.
[Abstract] [Full Text]


Home page
GutHome page
B Wesche, E Jaeckel, C Trautwein, H Wedemeyer, A Falorni, H Frank, A von zur Muhlen, M-P Manns, and G Brabant
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C
Gut, March 1, 2001; 48(3): 378 - 383.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Li, E. Lindholm, P. Almgren, A. Gustafsson, C. Forsblom, L. Groop, and T. Tuomi
Possible Human Leukocyte Antigen-Mediated Genetic Interaction between Type 1 and Type 2 Diabetes
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 574 - 582.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Törn, M. Landin-Olsson, A. Lernmark, J. P. Palmer, H. J. Arnqvist, G. Blohmé, F. Lithner, B. Littorin, L. Nyström, B. Scherstén, et al.
Prognostic Factors for the Course of {beta} Cell Function in Autoimmune Diabetes
J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4619 - 4623.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
E. S. Husebye, G. Gebre-Medhin, T. Tuomi, J. Perheentupa, M. Landin-Olsson, J. Gustafsson, F. Rorsman, and O. Kampe
Autoantibodies against Aromatic L-Amino Acid Decarboxylase in Autoimmune Polyendocrine Syndrome Type I
J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 147 - 150.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1992 by the American Diabetes Association.